Tumor necrosis factor (TNF) is a cytokine that mediates tumor necrosis. To date, 20 different
members of the TNF super‐family and 21 different receptors have been identified. All …

Cytotoxic activity of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL/Apo-2
ligand), used alone or in different combinations with either a low (1.5 Gy) or a high (15 Gy) …

The response of T-cells to peptide antigen plus major histocompatibility complex (MHC)
consists of a series of cellular events collectively called T-cell activation. An essential …

We describe a new two-step culture method for mass production in vitro of erythroid cells from
either CD34 + (10 5 cells/mL) or light-density (10 6 cells/mL) cells purified from the blood …

The ecotoxicity of pristine graphene nanoparticles (GNC1, PGMF) in model marine organisms
was investigated. PGMF resulted more toxic than GNC1 to the bioluminescent bacterium …

Progress in the understanding of the biology of perinatal tissues has contributed to the
breakthrough revelation of the therapeutic effects of perinatal derivatives (PnD), namely birth-…

Endothelial cells express tumor necrosis factor–related apoptosis-inducing ligand (TRAIL)
receptors, but the function of TRAIL in endothelial cells is not completely understood. We …

In order to investigate the biologic activity of tumor necrosis factor–related apoptosis-inducing
ligand (TRAIL) on human erythropoiesis, glycophorin A (GPA) + erythroid cells were …

Tissue engineering is widely recognized as a promising approach for bone repair and
reconstruction. Several attempts have been made to achieve materials that must be compatible, …

Background and aims Gestational diabetes (GDM) is associated with increased oxidative
stress and overexpression of inflammatory cytokines, both of which might lead to endothelial …